Peptide Therapeutics Market Growth Through 2030 Creates New Strategic Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Peptide Therapeutics Market Forecast Highlighting Growth From $54.62 Billion To $83.57 Billion
The market for peptide therapeutics has experienced swift expansion in recent years, climbing from $49.21 billion in 2025 to $54.62 billion in 2026, which represents a compound annual growth rate (CAGR) of 11.0%. Several factors drove its historical growth, including the early embrace of peptide-based medications, progress in peptide synthesis methods, a rising prevalence of chronic and rare conditions, breakthroughs in pharmacology and biochemistry, and an expanding presence of contract research organizations.
The peptide therapeutics market is anticipated to experience swift expansion over the coming years. By 2030, its value is projected to reach $83.57 billion, achieving a compound annual growth rate (CAGR) of 11.2%. This upward trajectory in the forecast period is fueled by the emergence of personalized medicine, heightened funding for peptide-based treatments, the application of artificial intelligence in drug discovery, the scaling up of biologics manufacturing, and the expansion of healthcare solutions in developing markets. Key developments shaping this period include the creation of precisely targeted peptide drugs, breakthroughs in delivery technologies for peptides, the rise of multi-functional therapeutic peptides, advancements in both natural peptide extraction and synthesis, as well as innovations in multi-functional therapeutic peptides.
Download A Free Sample Report For Comprehensive Market Insights:
Peptide Therapeutics Market Development Factors: Which Trends Are Supporting Demand?
A growing burden of chronic diseases is anticipated to drive expansion in the peptide therapeutics market. These conditions are enduring illnesses that often cannot be fully cured, though they may occasionally be managed or treated successfully. The rising prevalence is linked to higher consumption of tobacco, poor dietary habits, lack of physical activity, excessive alcohol intake, and other factors. Peptide therapeutics play a key role in preventing and addressing certain chronic diseases. For example, according to the National Library of Medicine, a US-based agency, it was reported in January 2023 that the number of Americans aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Consequently, this rise in chronic disease prevalence is expected to be a major driving force for the peptide therapeutics industry throughout the forecast period.
Peptide Therapeutics Market Segment Landscape And Growth Potential
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
Peptide Therapeutics Market Transformation Trends: Which Innovations Are Driving Change?
Major players in the peptide therapeutics market are concentrating on introducing innovative solutions, like cell culture processes, to strengthen their market position. Cell culture process refers to the cultivation of cells in a controlled environment outside their natural habitat, which begins with isolating target cells from living tissues and then maintaining them under regulated conditions. For example, in June 2023, Evonik Industries AG, a German specialty chemicals firm, introduced cQrex KC—a next-generation peptide designed for biopharmaceutical applications, tailored for the cell culture processes involved in producing biological drugs. This product allows developers of cell culture processes to improve cystine supply and boost overall productivity. cQrex KC also aids in the development of vaccines, viral vectors, and gene therapy vectors.
Peptide Therapeutics Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
Access The Complete Peptide Therapeutics Market Report:
Peptide Therapeutics Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
